A Pancancer Study of PIEZO1 as a Prognosis and Immune Biomarker of Human Tumors

Figure 3

The correlation between the expression level of PIEZO1 and prognostic survival in TCGA tumors. (a) GEPIA2 utilized to analyze the relationships between the PIEZO1 expression level and overall survival (OS) of KIRC, LGG, LIHC, LUAD, and LUSC in all TCGA tumors. (b) Relationships between PIEZO1 gene expression and disease-free survival (DFS) of ACC, CHOL, GBM, LGG, LIHC, and LUHC are assessed. The survival map and Kaplan–Meier curves are presented.

(a)

(b)